Cancer Res Treat.  2010 Sep;42(3):125-129.

RNA Regulation in Neurologic Disease and Cancer

• Darnell RB

Abstract

The paraneoplastic neurologic diseases (PNDs) are brain degenerations that develop in the setting of clinically inapparent cancers. PNDs arise when common cancers express brain proteins, triggering an anti-tumor immune response and tumor immunity. Research on these brain-cancer proteins has revealed a new world of neuron-specific RNA binding proteins whose functions may be aberrantly used by tumor cells. Efforts to gain insight into their function has led to the development of new methods and strategies to understand RNA protein regulation in living tissues.

Keyword

Paraneoplastic neurologic degeneration; Nova; RNA binding protein; CLIP; Tumor immunity

MeSH Terms

Brain
Proteins
RNA
RNA-Binding Proteins
Proteins
RNA
RNA-Binding Proteins

Reference

1. Darnell RB, Furneaux HM, Posner JB. Characterization of antigens bound by CSF and serum of a patient with cerebellar degeneration: coexpression in Purkinje cells and tumor lines of neuroectodermal origin. Neurology. 1989; 39(Suppl 1):385. PMID: 2927647.

2. Darnell RB, Furneaux HM, Posner JB. Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors. J Neurosci. 1991; 11:1224–1230. PMID: 1851215.

3. McKeever MO, Darnell RB. NAP, a human cerebellar degeneration antigen, is a novel, neuron specific, adaptin family member [abstract]. Soc Neurosci. 1992; Abstr 18, 1092.

4. Newman LS, McKeever MO, Okano HJ, Darnell RB. Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. Cell. 1995; 82:773–783. PMID: 7671305.

5. Darnell RB. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci U S A. 1996; 93:4529–4536. PMID: 8643438.

6. Musunuru K, Darnell RB. Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu Rev Neurosci. 2001; 24:239–262. PMID: 11283311.

7. Dredge BK, Polydorides AD, Darnell RB. The splice of life: alternative splicing and neurological disease. Nat Rev Neurosci. 2001; 2:43–50. PMID: 11253358.

8. Licatalosi DD, Darnell RB. Splicing regulation in neurologic disease. Neuron. 2006; 52:93–101. PMID: 17015229.

9. Albert ML, Darnell RB. Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer. 2004; 4:36–44. PMID: 14708025.

10. Roberts WK, Darnell RB. Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol. 2004; 16:616–622. PMID: 15342008.

11. Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 2006; 33:270–298. PMID: 16769417.

12. Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med. 1998; 4:1321–1324. PMID: 9809559.

13. Albert ML, Austin LM, Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol. 2000; 47:9–17. PMID: 10632096.

14. Frank MO. Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer. PLoS One. 2010; in press.

15. Santomasso BD, Roberts WK, Thomas A, Williams T, Blachere NE, Dudley ME, et al. A T-cell receptor associated with naturally occurring human tumor immunity. Proc Natl Acad Sci U S A. 2007; 104:19073–19078. PMID: 18045792.

16. Buckanovich RJ, Posner JB, Darnell RB. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron. 1993; 11:657–672. PMID: 8398153.

17. Yang YY, Yin GL, Darnell RB. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci U S A. 1998; 95:13254–13259. PMID: 9789075.

18. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology. 1985; 35:538–543. PMID: 2984600.

19. Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell. 1991; 67:325–333. PMID: 1655278.

20. Hinman MN, Lou H. Diverse molecular functions of Hu proteins. Cell Mol Life Sci. 2008; 65:3168–3181. PMID: 18581050.

21. Buckanovich RJ, Yang YY, Darnell RB. The onconeural antigen Nova-1 is a neuronspecific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci. 1996; 16:1114–1122. PMID: 8558240.

22. Green R, Ellington AD, Bartel DP, Szostak JW. In vitro genetic analysis: selection and amplification of rare functional nucleic acids. Methods Compan Methods Enzymol. 1991; 2:75–86.

23. Szostak JW, Ellington AD. In vitro selection of functional RNA sequences. The RNA world. 1993. Woodbury, NY: Cold Spring Harbor Laboratory Press;p. 511–533.

24. Buckanovich RJ, Darnell RB. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol Cell Biol. 1997; 17:3194–3201. PMID: 9154818.

25. Jensen KB, Musunuru K, Lewis HA, Burley SK, Darnell RB. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. Proc Natl Acad Sci U S A. 2000; 97:5740–5745. PMID: 10811881.

26. Lewis HA, Musunuru K, Jensen KB, Edo C, Chen H, Darnell RB, et al. Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell. 2000; 100:323–332. PMID: 10676814.

27. Dredge BK, Darnell RB. Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol Cell Biol. 2003; 23:4687–4700. PMID: 12808107.

28. Dredge BK, Stefani G, Engelhard CC, Darnell RB. Nova autoregulation reveals dual functions in neuronal splicing. EMBO J. 2005; 24:1608–1620. PMID: 15933722.

29. Darnell RB. Developing global insight into RNA regulation. Cold Spring Harb Symp Quant Biol. 2006; 71:321–327. PMID: 17381312.

30. Ule J, Ule A, Spencer J, Williams A, Hu JS, Cline M, et al. Nova regulates brainspecific splicing to shape the synapse. Nat Genet. 2005; 37:844–852. PMID: 16041372.

31. Ule J, Stefani G, Mele A, Ruggiu M, Wang X, Taneri B, et al. An RNA map predicting Nova-dependent splicing regulation. Nature. 2006; 444:580–586. PMID: 17065982.

32. Ule J, Jensen KB, Ruggiu M, Mele A, Ule A, Darnell RB. CLIP identifies Novaregulated RNA networks in the brain. Science. 2003; 302:1212–1215. PMID: 14615540.

33. Darnell RB. HITS-CLIP: panoramic views of protein-RNA regulation in living cells. Wiley Interdiscip Rev. 2010; 1:266–286.

34. Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, Chi SW, et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature. 2008; 456:464–469. PMID: 18978773.

35. Licatalosi DD, Darnell RB. RNA processing and its regulation: global insights into biological networks. Nat Rev Genet. 2010; 11:75–87. PMID: 20019688.

36. Zhang C, Frias MA, Mele A, Ruggiu M, Eom T, Marney CB, et al. Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls. Science. 2010; 329:439–443. PMID: 20558669.

37. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010; 141:129–141. PMID: 20371350.

38. König J, Zarnack K, Rot G, Curk T, Kayikci M, Zupan B, et al. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol. 2010; 17:909–915. PMID: 20601959.

39. Sanford JR, Wang X, Mort M, Vanduyn N, Cooper DN, Mooney SD, et al. Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. Genome Res. 2009; 19:381–394. PMID: 19116412.

40. Yeo GW, Coufal NG, Liang TY, Peng GE, Fu XD, Gage FH. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat Struct Mol Biol. 2009; 16:130–137. PMID: 19136955.

41. Xue Y, Zhou Y, Wu T, Zhu T, Ji X, Kwon YS, et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell. 2009; 36:996–1006. PMID: 20064465.

42. Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature. 2009; 460:479–486. PMID: 19536157.

43. Zisoulis DG, Lovci MT, Wilbert ML, Hutt KR, Liang TY, Pasquinelli AE, et al. Comprehensive discovery of endogenous Argonaute binding sites in Caenorhabditis elegans. Nat Struct Mol Biol. 2010; 17:173–179. PMID: 20062054.

44. Xu M, Medvedev S, Yang J, Hecht NB. MIWI-independent small RNAs (MSY-RNAs) bind to the RNA-binding protein, MSY2, in male germ cells. Proc Natl Acad Sci U S A. 2009; 106:12371–12376. PMID: 19597149.